Metraipolis › archive › dc_f8be0bfdd4bd

Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to… — Europe PMC PMID:41694365

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41694365
DOI: 10.3389/fimmu.2026.1714022
License (as archived): solo-consultazione
Archived: 2026-11-06T09:56:29.707Z
SHA-256 of the archived text: c18266e90762ab6ea0dfd37d9c1d1d0e6ffa3a34cd611a7272602ba9996cef77
Stable URL of this page: https://metraipolis.com/documento/dc_f8be0bfdd4bd

How to cite

Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to… — Europe PMC PMID:41694365 — Europe PMC (en), https://europepmc.org/article/MED/41694365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8be0bfdd4bd (Metraipolis archive dc_f8be0bfdd4bd, sha256 c18266e90762ab6ea0dfd37d9c1d1d0e6ffa3a34cd611a7272602ba9996cef77)

BibTeX

@misc{dcf8be0bfdd4bd,
  title = {Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to… — Europe PMC PMID:41694365},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41694365},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8be0bfdd4bd; sha256 c18266e90762ab6ea0dfd37d9c1d1d0e6ffa3a34cd611a7272602ba9996cef77},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41694365. Agents can read the archived copy with the MCP tool read_document.